Parathyroid carcinoma in multiple endocrine neoplasia type 1. case report and review of the literature

Hormones

Volumn 10, Issue 4, 2011, Pages 326-331

  del Pozo, Carlos ^a   García Pascual, Luis ^a   Balsells, Montserrat ^a   Barahona, María José ^a   Veloso, Enrique ^a   González, Clarisa ^a   Anglada Barceló, Jordi ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Hypercalcemia; Multiple endocrine neoplasia type 1 (MEN 1); Parathyroid carcinoma; Parathyroid surgery; Primary hyperparathyroidism

Indexed keywords

CALCIUM; CHROMOGRANIN; GASTRIN; INSULIN; LANSOPRAZOLE; PANCREAS ENZYME; PARATHYROID HORMONE; SECRETIN; SYNAPTOPHYSIN; THYROXINE;

ABDOMINAL PAIN; ADRENAL CORTEX ADENOMA; ADULT; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; EXON; EXON 3; FATTY LIVER; GASTRIN BLOOD LEVEL; GASTRINOMA; GENE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPOTHYROIDISM; IMMUNOREACTIVITY; MALE; MEN1 GENE; METASTASIS; MULTIPLE DRUG DOSE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PANCREATICODUODENECTOMY; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PRIMARY HYPERPARATHYROIDISM; REVIEW; SPLENECTOMY; SUBCLINICAL HYPOTHYROIDISM; THYROID NODULE; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRASOUND;

EID: 84855514407     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1325     Document Type: Review

References (24)

1. Carling T, 2005 Multiple endocrine neoplasia syndrome: genetic basis for clinical management. Curr Opin Oncology 17: 7-12.
2. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA, 1998 Multiple endocrine neoplasia type 1: clinical and genetics topics. Ann Intern Med 129: 484-494.
3. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA, 1992 Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 71: 197-205.
4. Troilo VL, D'Eredità G, Fischetti F, Berardi T, 2009 Parathyroid cancer as rare cause of primary hyperparathyroidism. Case report and review of the literature. G Chir 30: 432-436.
5. Schantz A, Castleman B, 1973 Parathyroid carcinoma: a study of 70 cases. Cancer 31: 600-605.
6. Bondeson L, Sandelin K, Grimelius L, 1993 Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 17: 820-829.
7. Erikson LA, Jin L, Papotti M, Lloyd RV, 2002 Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol 26: 344-349.
8. Tan MH, Morrison C, Wang P, et al, 2004 Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10: 6629-6637.
9. Gill AJ, Clarkson A, Gimm O, et al 2006 Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPTJT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30: 1140-1149.
10. Shane E, 2001 Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab 86: 485-493.
11. Mizusawa N, Uchino S, Iwata T, et al, 2006 Genetic analyses in patients with familial isolated hyperparathyroidism-jaw tumor syndrome. Clin Endocrinol 65: 9-16.
12. Shattuck TM, Välimäki S, Obara T, et al, 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349: 1722-1729.
13. Haven CJ, van Puijenbroek M, Tan MH, et al 2007 Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol 67: 370-376.
14. Hannan FM, Nesbit MA, Christie PT, Fratter C, Dudley NE, Thakker RV, 2008 Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene. Nat Clin Endocrinology Metab 4: 53-58.
15. Kelly TG, Shattuck TM, Reyes-Múgica M, et al 2006 Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 21: 1666-1671.
16. Agha A, Carpenter R, Bhattacharya S, Edmonson SJ, Carlsen E, Monson JP, 2007 Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Invest 30: 145-149.
17. Shih RY, Fackler S, Maturo S, True MW, Brennan J, Wells D, 2009 Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract 15: 567-572.
18. Sato M, Miyauchi A, Namihira H, et al, 2000 A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine 12: 223-226.
19. Dionisi S, Minisola S, Pepe J, et al, 2002 Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 77: 866-869.
20. Wilkins BJ, Lewis JS, 2009 Non-Functional Parathyroid Carcinoma: A Review of the Literature and Report of a Case Requiring Extensive Surgery. Head Neck Pathol 3: 140-149.
21. Fernandez-Ranvier GG, Jensen K, Khanafshar E, et al, 2007 Nonfunctioning parathyroid carcinoma: case report and review of literature. Endoc Pract 13: 750-757.
22. Munson ND, Foote RL, Northcutt RC, et al, 2003 Parathyroid carcinoma: is there a role for adjuvant radiation therapy?. Cancer 98: 2378-2384.
23. Busaidy NL, Jimenez C, Habra MA, et al, 2004 Parathyroid carcinoma: a 22-year experience. Head Neck 26: 716-726.
24. Silverberg SJ, Rubin MR, Faiman C, et al, 2007 Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metabol 92: 3803-3808.